Grateful, I have been pounding the table for Acadia for months (ACAD) . . . has a best in class treatment for Parkinson's psychosis, which could also treat schizophrenia and potentially alzheimer's. Just finished Ph 2 and FDA told them not to bother with Ph. 3 . . . file NDA. . . has had a big run up but could run another 3-8 times conservatively. Baker Bros. is in them in a big way. ACAD will be bought out. This could be another PCYC . . . another Baker Bros. home run. I think its worth taking a look at. IMHO